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Introduction
Most cases of West Nile Virus infection are asymptomatic. 60% to
70% of neuro-invasive cases of West Nile virus infection result in
meningitis or encephalitis; however, West Nile encephalitis occurs
in less than 1% of patients infected with the West Nile virus.1

Case
Our patient is a 60 year old Caucasian female with a history of
antiphospholipid syndrome, an ischemic stroke in 1994 resulting
in warfarin therapy, hypertension, end stage renal disease
secondary to idiopathic glomerulonephritis status post cadaveric
renal transplant in 1995 on immunosuppressive therapy. She
presented with multiple febrile episodes and subjective chills one
day prior to admission. She was alert and oriented to person,
place and time, but appeared weak. She had no nuchal rigidity
and cardiovascular and pulmonary examinations were within
normal limits.
On admission she was on the following medications:
mycophenolate 1gm every 12 hours, daily administration of
atenolol 25mg, warfarin 4 mg daily, duloxetine 30mg, and
lorazepam 0.5 mg as needed for anxiety. She had no known drug
allergies. Her family history was unremarkable and she denied
the use of alcohol, tobacco, or illegal substances. Laboratory
values on admission are presented in Table 1.
She was admitted for fever workup. On hospital day 2, she
had a change in mental status, and therapy was initiated for
presumptive bacterial and viral meningitis, encephalitis, and
bacterial sinusitis. Computed tomography (CT) scan of the head
showed encephalomalacia and gliosis in the right posterior frontal
lobe and right basal ganglia. There was no new hemorrhage,
mass effect, midline shift or edema. With worsening mental
status, she was transferred to the intensive care unit (ICU) for
closer monitoring. She never required ventilator support. She
was later transferred to the general floor after 3 days in the ICU
when her mental status improved. She subsequently had an
abrupt worsening in her mental status. She also continued to
have febrile episodes (Figure 1) A magnetic resonance imaging
(MRI) of the brain also revealed cerebral volume loss.
She was re-admitted to the ICU and later transferred to the
Neurology ICU (NICU). A lumbar puncture (LP) was performed
on hospital day 2, 13 and 17. Each sample of cerebrospinal fluid
(CSF) was sent for polymerase chain reaction (PCR) (analysis
of Mycobacterium tuberculosis, Herpes simplex virus (HSV),
Cytomegalovirus and JC virus; Lyme (IgG, IgM), Toxoplasma
IgG; fungal, bacterial culture and India ink for Cryptococcus
which was all negative.
The ELIZA assay for CSF West Nile virus from hospital day
13 returned positive. The initial West Nile ELISA assay from
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Table 1. Laboratory Values on Admission
Sodium

134

(135 – 146)

mmol/L

Potassium

4.0

(3.5 – 5.0)

mmol/L

Chloride

101

(98 – 109)

mmol/L

CO2

24

(24 – 32)

mmol/L

Urea-Nitrogen

32

(7 – 26)

mg/dL

Glucose

104

(50 – 100)

mg/dL

WBC

8.7

(4 – 11)

B/L

HGB

11.4

(12.5 – 15)

g/dL

HCT

36.8

(36 – 46)

%

Platelet Count

185

(140 – 400)

B/L

LP

1

2

3

CSF Lymphocytes

23

86

93

hospital day 2 was negative ; however repeat testing on hospital
day 13 revealed elevated IgG of 2.03 (normal <1.3) and elevated
IgM of 5.27 (normal <0.9). All antibiotics were stopped on
hospital day 22. She later regained her mental status and was
almost back to her mental baseline. She was transferred out of
the NICU on hospital day 25.

Discussion
In the West Nile region of northern Uganda the first isolate of an
arbovirus was obtained from a febrile woman. The first reported
case of West Nile encephalitis was in the early 1950s in New York
resulting from an experimental treatment for advanced cancer.1
Almost forty years later, in 1999, cases of West Nile encephalitis
appeared in clusters in the United States2 with multiple cases
having been documented thereafter. Typically these cases peak
in the warm months of the year in the northeast in the months
of July to October.3 The West Nile virus is a single stranded RNA
flavivirus. The carriers of this virus are usually migratory birds
that have been bitten by an infected Culex mosquito (Figure 2).
In most patients infected with the West Nile virus, there is on
average a 10±5 days incubation period. In a subset of infected
individuals such as immunocompromised patients, viral
incubation can last up to 21 days.4 The most common clinical
presentation includes fever with a viral prodrome, however
tremors although uncommon can also be seen.5 The sensitivity
of ELISA to detect West Nile IgM increases based on the timing
of the sample, as successful isolation decreases as the disease
duration progresses.5 In West Nile encephalitis the virus crosses
the blood brain barrier and hence detection involves analysis
of the CSF. Real time PCR detects the infection in about half
of infected patients.6 IgM detection is the most common and
preferred test of choice. In addition to CSF and serum analysis
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Figure 1. Fever curve
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Humans

of IgM, imaging modalities such as MRI or CT of the brain may
be helpful in identifying the presence of central nervous system
inflammation.

Conclusion
Other causes of encephalitis or meningitis such as HSV and Lyme
disease should be ruled out prior to initiating treatment for West
Nile encephalitis. As shown in Figure 1, antiviral or antibiotics
have no effect on febrile episodes and treatment is generally
supportive. Complications such as cerebral edema, headaches
can occur after infection. Our patient had residual persistent
limb weakness which was managed with physical therapy.
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